Vaccines and immunization : Immunization : Japanese Encephalitis Project
JE Newsbriefs
An electronic newsletter and interim supplement on Japanese encephalitis
Published 2004–2009, JE Newsbriefs was a quarterly electronic newsletter for global health experts. It provided updates on PATH’s work to increase the availability in the developing world of a vaccine against Japanese encephalitis—a mosquito-borne illness that can cause severe neurological disability or death.
Click on the links below to access past issues of JE Newsbriefs archived in PATH’s Vaccine Resource Library.
- Cambodia introduces JE vaccine through routine immunization
- Biregional meeting on JE control looks at progress and next steps
- PATH’s JE project closes, JE control continues
- Coalition of partners to maintain momentum of JE control
- CDIBP proceeds with commissioning of new JE vaccine production facility
- Intercell’s IC51 JE vaccine for travelers gains regulatory approvals
- JE Control by 2015 details sustainable priorities for the future
- CDIBP JE vaccine facility nears mechanical completion
- GAVI Alliance commits to seek funding for JE vaccine introduction support
- International symposium presents advances in JE detection and prevention
- Vaccine production facilities unharmed in Chengdu’s major earthquake
- The Lancet article highlights inclusion of JE in GAVI Alliance strategy
- India aims to vaccinate 20 million more in third year of JE immunization strategy
- WHO advisory committee acknowledges safety of coadministering live JE and measles vaccines
- Cohort study assesses WHO JE surveillance standards
- Follow-up study shows long-term protection when measles and JE vaccines are given together
- Groundbreaking ceremony held for new facility at Chengdu Institute
- Studies initiated to advance JE control in Sri Lanka
- Biregional meeting marks progress and maps out next steps
- Study demonstrates long-term protection from single dose of SA 14-14-2 JE vaccine
- India and Nepal expand JE vaccination campaigns
- JE immunization highlighted at Global Vaccine Research Forum
- WHO/SEARO issues guidelines on SA 14-14-2 vaccine introduction
- Partner profile: Center for Vaccine Development, Mahidol University
- India protects 9 million children against JE
- Nepal safeguards 2 million children
- WHO updates position paper on JE vaccines
- Partner profile: Technip
- SEARO laboratory network established
- India approves licensure of SA 14-14-2 vaccine
- Public-sector pricing established
- Strategic Advisory Group of Experts addresses JE control through immunization
- JE Project-supported studies
- JE outbreak in India
- WHO committee reviews safety and efficacy of SA 14-14-2 vaccine
- JE control highlighted in BBC World documentary
- New JE e-learning tool on web and CD-ROM
- Nepal prepares the way for better JE control
- Partner profile: AFRIMS in Thailand
- JE on the move
- Interactive JE reporting system to debut in India
- Indonesia plans first nationwide assessment of JE
- The JE Core Working Group

